BioAge Labs, Inc. (BIOA)
20.50
+0.36
(+1.79%)
USD |
NASDAQ |
Feb 20, 16:00
20.50
0.00 (0.00%)
After-Hours: 16:23
BioAge Labs EPS Diluted (Quarterly) : -0.5626 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Plus Therapeutics, Inc. | -0.0412 |
| BioStem Technologies, Inc. | 0.0328 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Protokinetix, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.17M |
| Revenue (Quarterly) | 2.054M |
| Total Expenses (Quarterly) | 22.22M |
| Enterprise Value | 562.25M |
| Gross Profit Margin (Quarterly) | 97.61% |
| Profit Margin (Quarterly) | -982.0% |
| Earnings Yield | -10.31% |
| Normalized Earnings Yield | -10.36 |